Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Respiratory Research
Published in: Respiratory Research 1/2009

Open Access 01-12-2009 | Review

EAACI position paper on occupational rhinitis

Authors: Gianna Moscato, Olivier Vandenplas, Roy Gerth Van Wijk, Jean-Luc Malo, Luca Perfetti, Santiago Quirce, Jolanta Walusiak, Roberto Castano, Gianni Pala, Denyse Gautrin, Hans De Groot, Ilenia Folletti, Mona Rita Yacoub, Andrea Siracusa

Published in: Respiratory Research | Issue 1/2009

Login to get access

Abstract

The present document is the result of a consensus reached by a panel of experts from European and non-European countries on Occupational Rhinitis (OR), a disease of emerging relevance which has received little attention in comparison to occupational asthma. The document covers the main items of OR including epidemiology, diagnosis, management, socio-economic impact, preventive strategies and medicolegal issues. An operational definition and classification of OR tailored on that of occupational asthma, as well as a diagnostic algorithm based on steps allowing for different levels of diagnostic evidence are proposed. The needs for future research are pointed out. Key messages are issued for each item.
Appendix
Available only for authorised users
Literature
1.
Bousquet J, Van Cauwenberge P, Khaltaev N: Allergic rhinitis and its impact on asthma. J Allergy Clin Immunol 2001, 108:S147–334.PubMedCrossRef
2.
Vignola AM, Bousquet J: Rhinitis and asthma: a continuum of disease? Clin Exp Allergy 2001, 31:674–7.PubMedCrossRef
3.
Passalacqua G, Ciprandi G, Canonica GW: The nose-lung interaction in allergic rhinitis and asthma: united airways disease. Curr Opin Allergy Clin Immunol 2001, 1:7–13.PubMed
4.
5.
Togias A: Rhinitis and asthma: evidence for respiratory system integration. J Allergy Clin Immunol 2003, 111:1171–83. quiz 1184.PubMedCrossRef
6.
Bachert C, Vignola AM, Gevaert P, Leynaert B, Van Cauwenberge P, Bousquet J: Allergic rhinitis, rhinosinusitis, and asthma: one airway disease. Immunol Allergy Clin North Am 2004, 24:19–43.PubMedCrossRef
7.
Passalacqua G, Ciprandi G, Pasquali M, Guerra L, Canonica GW: An update on the asthma-rhinitis link. Curr Opin Allergy Clin Immunol 2004, 4:177–83.PubMedCrossRef
8.
9.
Siracusa A, Desrosiers M, Marabini A: Epidemiology of occupational rhinitis: prevalence, aetiology and determinants. Clin Exp Allergy 2000, 30:1519–34.PubMedCrossRef
10.
Gautrin D, Desrosiers M, Castano R: Occupational rhinitis. Curr Opin Allergy Clin Immunol 2006, 6:77–84.PubMed
11.
Walusiak J: Occupational upper airway disease. Curr Opin Allergy Clin Immunol 2006, 6:1–6.PubMed
12.
Christiani DC, Malo JL, Siracusa A: Upper airways involvement. In Asthma in the workplace. Edited by: Bernstein IL, Chan-Yeung M, Malo JL, Bernstein DI. New York: Taylor & Francis; 2006:785–796.CrossRef
13.
International Consensus Report on the diagnosis and management of rhinitis. International Rhinitis Management Working Group Allergy 1994,49(19):1–34.
14.
Ng ML, Warlow RS, Chrishanthan N, Ellis C, Walls R: Preliminary criteria for the definition of allergic rhinitis: a systematic evaluation of clinical parameters in a disease cohort (I). Clin Exp Allergy 2000, 30:1314–31.PubMedCrossRef
15.
Wang DY, Niti M, Smith JD, Yeoh KH, Ng TP: Rhinitis: do diagnostic criteria affect the prevalence and treatment? Allergy 2002, 57:150–4.PubMedCrossRef
16.
Castano R, Theriault G, Gautrin D: The definition of rhinitis and occupational rhinitis needs to be revisited. Acta Otolaryngol 2006, 126:1118–9.PubMedCrossRef
17.
Salvaggio JE, Taylor G, Weill H: Occupational asthma and rhinitis in occupational respiratory disease. US Department of Health and Human Services. Washington, DC 1986.
18.
Dykewicz MS, Fineman S, Skoner DP, Nicklas R, Lee R, Blessing-Moore J, et al.: Diagnosis and management of rhinitis: complete guidelines of the Joint Task Force on Practice Parameters in Allergy, Asthma and Immunology. American Academy of Allergy, Asthma, and Immunology. Ann Allergy Asthma Immunol 1998, 81:478–518.PubMedCrossRef
19.
European Commission: Information notices on diagnosis of occupational diseases. Luxembourg 1997.
20.
21.
Hellgren J, Karlsson G, Toren K: The dilemma of occupational rhinitis: management options. Am J Respir Med 2003, 2:333–41.PubMedCrossRef
22.
Storaas T, Steinsvag SK, Florvaag E, Irgens A, Aasen TB: Occupational rhinitis: diagnostic criteria, relation to lower airway symptoms and IgE sensitization in bakery workers. Acta Otolaryngol 2005, 125:1211–7.PubMedCrossRef
23.
Malo JL, Ghezzo H, L'Archeveque J, Lagier F, Perrin B, Cartier A: Is the clinical history a satisfactory means of diagnosing occupational asthma? Am Rev Respir Dis 1991, 143:528–32.PubMedCrossRef
24.
Vandenplas O, Malo JL: Definitions and types of work-related asthma: a nosological approach. Eur Respir J 2003, 21:706–12.PubMedCrossRef
25.
Bernstein IL, Chan-Yeung M, Malo JL, Bernstein DI: Definition and classification of asthma in the workplace. In Asthma in the workplace. 3rd edition. Edited by: Bernstein IL, Chan-Yeung M, Malo JL, Bernstein DI. New York: Taylor & Francis; 2006:1–8.CrossRef
26.
Nathan RA, Eccles R, Howarth PH, Steinsvag SK, Togias A: Objective monitoring of nasal patency and nasal physiology in rhinitis. J Allergy Clin Immunol 2005, 115:S442–59.PubMedCrossRef
27.
Howarth PH, Persson CG, Meltzer EO, Jacobson MR, Durham SR, Silkoff PE: Objective monitoring of nasal airway inflammation in rhinitis. J Allergy Clin Immunol 2005, 115:S414–41.PubMedCrossRef
28.
29.
Castano R, Theriault G: Defining and classifying occupational rhinitis. J Laryngol Otol 2006, 120:812–7.PubMedCrossRef
30.
Johansson SG, Hourihane JO, Bousquet J, Bruijnzeel-Koomen C, Dreborg S, Haahtela T, et al.: A revised nomenclature for allergy. An EAACI position statement from the EAACI nomenclature task force. Allergy 2001, 56:813–24.PubMedCrossRef
31.
Chan-Yeung M: Assessment of asthma in the workplace. ACCP consensus statement. American College of Chest Physicians. Chest 1995, 108:1084–117.PubMedCrossRef
32.
Meggs WJ, Elsheik T, Metzger WJ, Albernaz M, Bloch RM: Nasal pathology and ultrastructure in patients with chronic airway inflammation (RADS and RUDS) following an irritant exposure. J Toxicol Clin Toxicol 1996, 34:383–96.PubMedCrossRef
33.
Leroyer C, Malo JL, Girard D, Dufour JG, Gautrin D: Chronic rhinitis in workers at risk of reactive airways dysfunction syndrome due to exposure to chlorine. Occup Environ Med 1999, 56:334–8.PubMedPubMedCentralCrossRef
34.
Hoffman CD, Henneberger PK, Olin AC, Mehta A, Toren K: Exposure to ozone gases in pulp mills and the onset of rhinitis. Scand J Work Environ Health 2004, 30:445–9.PubMedCrossRef
35.
Brooks SM, Weiss MA, Bernstein IL: Reactive airways dysfunction syndrome (RADS). Persistent asthma syndrome after high level irritant exposures. Chest 1985, 88:376–84.PubMedCrossRef
36.
Meggs WJ: RADS and RUDS – the toxic induction of asthma and rhinitis. J Toxicol Clin Toxicol 1994, 32:487–501.PubMedCrossRef
37.
Castano R, Theriault G, Gautrin D: Categorizing nasal septal perforations of occupational origin as cases of corrosive rhinitis. Am J Ind Med 2007, 50:150–3.PubMedCrossRef
38.
Cullinan P, Cook A, Gordon S, Nieuwenhuijsen MJ, Tee RD, Venables KM, et al.: Allergen exposure, atopy and smoking as determinants of allergy to rats in a cohort of laboratory employees. Eur Respir J 1999, 13:1139–43.PubMedCrossRef
39.
Rodier F, Gautrin D, Ghezzo H, Malo JL: Incidence of occupational rhinoconjunctivitis and risk factors in animal-health apprentices. J Allergy Clin Immunol 2003, 112:1105–11.PubMedCrossRef
40.
Cullinan P, Cook A, Nieuwenhuijsen MJ, Sandiford C, Tee RD, Venables KM, et al.: Allergen and dust exposure as determinants of work-related symptoms and sensitization in a cohort of flour-exposed workers; a case-control analysis. Ann Occup Hyg 2001, 45:97–103.PubMed
41.
Gautrin D, Ghezzo H, Infante-Rivard C, Malo JL: Incidence and host determinants of work-related rhinoconjunctivitis in apprentice pastry-makers. Allergy 2002, 57:913–8.PubMedCrossRef
42.
Chloros D, Sichletidis L, Kyriazis G, Vlachogianni E, Kottakis I, Kakoura M: Respiratory effects in workers processing dried tobacco leaves. Allergol Immunopathol (Madr) 2004, 32:344–51.CrossRef
43.
Hellgren J, Eriksson C, Karlsson G, Hagberg S, Olin AC, Toren K: Nasal symptoms among workers exposed to soft paper dust. Int Arch Occup Environ Health 2001, 74:129–32.PubMedCrossRef
44.
Kraus T, Pfahlberg A, Gefeller O, Raithel HJ: Respiratory symptoms and diseases among workers in the soft tissue producing industry. Occup Environ Med 2002, 59:830–5.PubMedPubMedCentralCrossRef
45.
Laumbach RJ, Fiedler N, Gardner CR, Laskin DL, Fan ZH, Zhang J, et al.: Nasal effects of a mixture of volatile organic compounds and their ozone oxidation products. J Occup Environ Med 2005, 47:1182–9.PubMedCrossRef
46.
Shusterman D, Balmes J, Avila PC, Murphy MA, Matovinovic E: Chlorine inhalation produces nasal congestion in allergic rhinitics without mast cell degranulation. Eur Respir J 2003, 21:652–7.PubMedCrossRef
47.
Shusterman D, Balmes J, Murphy MA, Tai CF, Baraniuk J: Chlorine inhalation produces nasal airflow limitation in allergic rhinitic subjects without evidence of neuropeptide release. Neuropeptides 2004, 38:351–8.PubMedCrossRef
48.
Shusterman DJ, Murphy MA, Balmes JR: Subjects with seasonal allergic rhinitis and nonrhinitic subjects react differentially to nasal provocation with chlorine gas. J Allergy Clin Immunol 1998, 101:732–40.PubMedCrossRef
49.
Shusterman D, Murphy MA, Balmes J: Differences in nasal irritant sensitivity by age, gender, and allergic rhinitis status. Int Arch Occup Environ Health 2003, 76:577–83.PubMedCrossRef
50.
Shusterman D, Tarun A, Murphy MA, Morris J: Seasonal allergic rhinitic and normal subjects respond differentially to nasal provocation with acetic acid vapor. Inhal Toxicol 2005, 17:147–52.PubMedCrossRef
51.
Hytonen M, Kanerva L, Malmberg H, Martikainen R, Mutanen P, Toikkanen J: The risk of occupational rhinitis. Int Arch Occup Environ Health 1997, 69:487–90.PubMedCrossRef
52.
Ruoppi P, Koistinen T, Susitaival P, Honkanen J, Soininen H: Frequency of allergic rhinitis to laboratory animals in university employees as confirmed by chamber challenges. Allergy 2004, 59:295–301.PubMedCrossRef
53.
Archambault S, Malo JL, Infante-Rivard C, Ghezzo H, Gautrin D: Incidence of sensitization, symptoms, and probable occupational rhinoconjunctivitis and asthma in apprentices starting exposure to latex. J Allergy Clin Immunol 2001, 107:921–3.PubMedCrossRef
54.
Draper A, Newman Taylor A, Cullinan P: Estimating the incidence of occupational asthma and rhinitis from laboratory animal allergens in the UK, 1999–2000. Occup Environ Med 2003, 60:604–5.PubMedPubMedCentralCrossRef
55.
Heederik D, Venables KM, Malmberg P, Hollander A, Karlsson AS, Renstrom A, et al.: Exposure-response relationships for work-related sensitization in workers exposed to rat urinary allergens: results from a pooled study. J Allergy Clin Immunol 1999, 103:678–84.PubMedCrossRef
56.
Hollander A, Heederik D, Doekes G: Respiratory allergy to rats: exposure-response relationships in laboratory animal workers. Am J Respir Crit Care Med 1997, 155:562–7.PubMedCrossRef
57.
Musk AW, Venables KM, Crook B, Nunn AJ, Hawkins R, Crook GD, et al.: Respiratory symptoms, lung function, and sensitisation to flour in a British bakery. Br J Ind Med 1989, 46:636–42.PubMedPubMedCentral
58.
Houba R, Heederik D, Doekes G: Wheat sensitization and work-related symptoms in the baking industry are preventable. An epidemiologic study. Am J Respir Crit Care Med 1998, 158:1499–503.PubMedCrossRef
59.
Liebers V, Hoernstein M, Baur X: Humoral immune response to the insect allergen Chi t I in aquarists and fish-food factory workers. Allergy 1993, 48:236–9.PubMedCrossRef
60.
Houba R, Heederik DJ, Doekes G, van Run PE: Exposure-sensitization relationship for alpha-amylase allergens in the baking industry. Am J Respir Crit Care Med 1996, 154:130–6.PubMedCrossRef
61.
Cullinan P, Harris JM, Newman Taylor AJ, Hole AM, Jones M, Barnes F, et al.: An outbreak of asthma in a modern detergent factory. Lancet 2000, 356:1899–900.PubMedCrossRef
62.
Gautrin D, Ghezzo H, Infante-Rivard C, Malo JL: Natural history of sensitization, symptoms and occupational diseases in apprentices exposed to laboratory animals. Eur Respir J 2001, 17:904–8.PubMedCrossRef
63.
de Meer G, Postma DS, Heederik D: Bronchial responsiveness to adenosine-5'-monophosphate and methacholine as predictors for nasal symptoms due to newly introduced allergens. A follow-up study among laboratory animal workers and bakery apprentices. Clin Exp Allergy 2003, 33:789–94.PubMedCrossRef
64.
Walusiak J, Hanke W, Gorski P, Palczynski C: Respiratory allergy in apprentice bakers: do occupational allergies follow the allergic march? Allergy 2004, 59:442–50.PubMedCrossRef
65.
Schumacher MJ, Tait BD, Holmes MC: Allergy to murine antigens in a biological research institute. J Allergy Clin Immunol 1981, 68:310–8.PubMedCrossRef
66.
Beeson MF, Dewdney JM, Edwards RG, Lee D, Orr RG: Prevalence and diagnosis of laboratory animal allergy. Clin Allergy 1983, 13:433–42.PubMedCrossRef
67.
Mapp CE: Genetics and the occupational environment. Curr Opin Allergy Clin Immunol 2005, 5:113–8.PubMedCrossRef
68.
Siracusa A, Marabini A: Smoking and asthma in the workplace. Am J Respir Crit Care Med 1997, 155:1168.PubMedCrossRef
69.
Nielsen GD, Olsen O, Larsen ST, Lovik M, Poulsen LK, Glue C, et al.: IgE-mediated sensitisation, rhinitis and asthma from occupational exposures. Smoking as a model for airborne adjuvants? Toxicology 2005, 216:87–105.PubMedCrossRef
70.
Siracusa A, Marabini A, Folletti I, Moscato G: Smoking and occupational asthma. Clin Exp Allergy 2006, 36:577–84.PubMedCrossRef
71.
Gautrin D, Ghezzo H, Infante-Rivard C, Malo JL: Host determinants for the development of allergy in apprentices exposed to laboratory animals. Eur Respir J 2002, 19:96–103.PubMedCrossRef
72.
Leynaert B, Neukirch F, Demoly P, Bousquet J: Epidemiologic evidence for asthma and rhinitis comorbidity. J Allergy Clin Immunol 2000, 106:S201–5.PubMedCrossRef
73.
Braunstahl GJ, Kleinjan A, Overbeek SE, Prins JB, Hoogsteden HC, Fokkens WJ: Segmental bronchial provocation induces nasal inflammation in allergic rhinitis patients. Am J Respir Crit Care Med 2000, 161:2051–7.PubMedCrossRef
74.
Malo JL, Lemière C, Desjardins A, Cartier A: Prevalence and intensity of rhinoconjunctivitis in subjects with occupational asthma. Eur Respir J 1997, 10:1513–5.PubMedCrossRef
75.
Vandenplas O, Ghezzo H, Munoz X, Moscato G, Perfetti L, Lemière C, et al.: What are the questionnaire items most useful in identifying subjects with occupational asthma? Eur Respir J 2005, 26:1056–63.PubMedCrossRef
76.
Gross NJ: Allergy to laboratory animals: epidemiologic, clinical, and physiologic aspects, and a trial of cromolyn in its management. J Allergy Clin Immunol 1980, 66:158–65.PubMedCrossRef
77.
Cortona G, Pisati G, Dellabianca A, Moscato G: [Respiratory occupational allergies: the experience of the Hospital Operative Unit of Occupational Medicine in Lombardy from 1990 to 1998]. G Ital Med Lav Ergon 2001, 23:64–70.PubMed
78.
Grammer LC, Ditto AM, Tripathi A, Harris KE: Prevalence and onset of rhinitis and conjunctivitis in subjects with occupational asthma caused by trimellitic anhydride (TMA). J Occup Environ Med 2002, 44:1179–81.PubMedCrossRef
79.
Munoz X, Cruz MJ, Orriols R, Bravo C, Espuga M, Morell F: Occupational asthma due to persulfate salts: diagnosis and follow-up. Chest 2003, 123:2124–9.PubMedCrossRef
80.
Moscato G, Pignatti P, Yacoub MR, Romano C, Spezia S, Perfetti L: Occupational asthma and occupational rhinitis in hairdressers. Chest 2005, 128:3590–8.PubMedCrossRef
81.
Karjalainen A, Martikainen R, Klaukka T, Saarinen K, Uitti J: Risk of asthma among Finnish patients with occupational rhinitis. Chest 2003, 123:283–8.PubMedCrossRef
82.
Elliott L, Heederik D, Marshall S, Peden D, Loomis D: Progression of self-reported symptoms in laboratory animal allergy. J Allergy Clin Immunol 2005, 116:127–32.PubMedCrossRef
83.
Bousquet J, Annesi-Maesano I, Carat F, Leger D, Rugina M, Pribil C, et al.: Characteristics of intermittent and persistent allergic rhinitis: DREAMS study group. Clin Exp Allergy 2005, 35:728–32.PubMedCrossRef
84.
Demoly P, Bozonnat MC, Dacosta P, Daures JP: The diagnosis of asthma using a self-questionnaire in those suffering from allergic rhinitis: a pharmaco-epidemiological survey in everyday practice in France. Allergy 2006, 61:699–704.PubMedCrossRef
85.
ATS/ERS Recommendations for Standardized Procedures for the Online and Offline Measurement of Exhaled Lower Respiratory Nitric Oxide and Nasal Nitric Oxide, 2005 Am J Respir Crit Care Med 2005, 171:912–30.
86.
Bernstein DI, Korbee L, Stauder T, Bernstein JA, Scinto J, Herd ZL, et al.: The low prevalence of occupational asthma and antibody-dependent sensitization to diphenylmethane diisocyanate in a plant engineered for minimal exposure to diisocyanates. J Allergy Clin Immunol 1993, 92:387–96.PubMedCrossRef
87.
88.
Malm L, Gerth van Wijk R, Bachert C: Guidelines for nasal provocations with aspects on nasal patency, airflow, and airflow resistance. International Committee on Objective Assessment of the Nasal Airways, International Rhinologic Society. Rhinology 2000, 38:1–6.PubMed
89.
Clement PA, Gordts F: Consensus report on acoustic rhinometry and rhinomanometry. Rhinology 2005, 43:169–79.PubMed
90.
Starling-Schwanz R, Peake HL, Salome CM, Toelle BG, Ng KW, Marks GB, et al.: Repeatability of peak nasal inspiratory flow measurements and utility for assessing the severity of rhinitis. Allergy 2005, 60:795–800.PubMedCrossRef
91.
Jones AS, Viani L, Phillips D, Charters P: The objective assessment of nasal patency. Clin Otolaryngol Allied Sci 1991, 16:206–11.PubMedCrossRef
92.
Holmstrom M, Scadding GK, Lund VJ, Darby YC: Assessment of nasal obstruction. A comparison between rhinomanometry and nasal inspiratory peak flow. Rhinology 1990, 28:191–6.PubMed
93.
Lund VJ, Flood J, Sykes AP, Richards DH: Effect of fluticasone in severe polyposis. Arch Otolaryngol Head Neck Surg 1998, 124:513–8.PubMedCrossRef
94.
Clarke RW, Jones AS, Richardson H: Peak nasal inspiratory flow – the plateau effect. J Laryngol Otol 1995, 109:399–402.PubMedCrossRef
95.
Larivee Y, Leon Z, Salas-Prato M, Ganeva E, Desrosiers M: Evaluation of the nasal response to histamine provocation with acoustic rhinometry. J Otolaryngol 2001, 30:319–23.PubMedCrossRef
96.
Pirila T, Nuutinen J: Acoustic rhinometry, rhinomanometry and the amount of nasal secretion in the clinical monitoring of the nasal provocation test. Clin Exp Allergy 1998, 28:468–77.PubMedCrossRef
97.
Airaksinen L, Tuomi T, Vanhanen M, Voutilainen R, Toskala E: Use of nasal provocation test in the diagnostics of occupational rhinitis. Rhinology 2007, 45:40–6.PubMed
98.
Scadding G, Lund V: Investigative Rhinology. London: Taylor and Francis; 2004.CrossRef
99.
Ciprandi G, Vizzaccaro A, Cirillo I, Tosca M, Massolo A, Passalacqua G: Nasal eosinophils display the best correlation with symptoms, pulmonary function and inflammation in allergic rhinitis. Int Arch Allergy Immunol 2005, 136:266–72.PubMedCrossRef
100.
Struben VM, Wieringa MH, Feenstra L, de Jongste JC: Nasal nitric oxide and nasal allergy. Allergy 2006, 61:665–70.PubMedCrossRef
101.
Gerth van Wijk RG, de Graaf-in 't Veld C, Garrelds IM: Nasal hyperreactivity. Rhinology 1999, 37:50–5.PubMed
102.
Marquez F, Sastre J, Hernandez G, Cenjor C, Sanchez-Hernandez JM, Sanchez J, et al.: Nasal hyperreactivity to methacholine measured by acoustic rhinometry in asymptomatic allergic and perennial nonallergic rhinitis. Am J Rhinol 2000, 14:251–6.PubMedCrossRef
103.
Gerth van Wijk R, Dieges PH: Nasal reactivity to histamine and methacholine: two different forms of upper airway responsiveness. Rhinology 1994, 32:119–22.PubMed
104.
Plavec D, Somogyi-Zalud E, Godnic-Cvar J: Modified method of nonspecific nasal provocation with histamine for routine use. Ann Allergy 1994, 72:321–8.PubMed
105.
Braat JP, Mulder PG, Fokkens WJ, van Wijk RG, Rijntjes E: Intranasal cold dry air is superior to histamine challenge in determining the presence and degree of nasal hyperreactivity in nonallergic noninfectious perennial rhinitis. Am J Respir Crit Care Med 1998, 157:1748–55.PubMedCrossRef
106.
Togias A, Krishnamurthy A, Proud D, Kagey-Sobotka A, Lichtenstein LM, Naclerio RM: Antigen AG augments the upper airway reaction to cold dry air. Am Rev Respir Dis 1991, 143.
107.
Walden SM, Proud D, Lichtenstein LM, Kagey-Sobotka A, Naclerio RM: Antigen-provoked increase in histamine reactivity. Observations on mechanisms. Am Rev Respir Dis 1991, 144:642–8.PubMedCrossRef
108.
Baroody FM, Cruz AA, Lichtenstein LM, Kagey-Sobotka A, Proud D, Naclerio RM: Intranasal beclomethasone inhibits antigen-induced nasal hyperresponsiveness to histamine. J Allergy Clin Immunol 1992, 90:373–6.PubMedCrossRef
109.
Klementsson H, Andersson M, Pipkorn U: Allergen-induced increase in nonspecific nasal reactivity is blocked by antihistamines without a clear-cut relationship to eosinophil influx. J Allergy Clin Immunol 1990, 86:466–72.PubMedCrossRef
110.
Sanico AM, Philip G, Lai GK, Togias A: Hyperosmolar saline induces reflex nasal secretions, evincing neural hyperresponsiveness in allergic rhinitis. J Appl Physiol 1999, 86:1202–10.PubMedCrossRef
111.
Renstrom A, Malmberg P, Larsson K, Sundblad BM, Larsson PH: Prospective study of laboratory-animal allergy: factors predisposing to sensitization and development of allergic symptoms. Allergy 1994, 49:548–52.PubMedCrossRef
112.
Cullinan P, Lowson D, Nieuwenhuijsen MJ, Sandiford C, Tee RD, Venables KM, et al.: Work related symptoms, sensitisation, and estimated exposure in workers not previously exposed to flour. Occup Environ Med 1994, 51:579–83.PubMedPubMedCentralCrossRef
113.
Cristaudo A, Sera F, Severino V, De Rocco M, Di Lella E, Picardo M: Occupational hypersensitivity to metal salts, including platinum, in the secondary industry. Allergy 2005, 60:159–64.PubMedCrossRef
114.
Krakowiak A, Krawczyk P, Szulc B, Wiszniewska M, Kowalczyk M, Walusiak J, et al.: Prevalence and host determinants of occupational bronchial asthma in animal shelter workers. Int Arch Occup Environ Health 2007,80(5):423–32. Epub 2006 Oct 5.PubMedCrossRef
115.
Hytonen M, Sala E: Nasal provocation test in the diagnostics of occupational allergic rhinitis. Rhinology 1996, 34:86–90.PubMed
116.
Litvyakova LI, Baraniuk JN: Nasal provocation testing: a review. Ann Allergy Asthma Immunol 2001, 86:355–64.PubMedCrossRef
117.
Rajakulasingam K: Nasal provocation testing. In Middleton's allergy principles & practice. Edited by: Adkinson NF Jr, Yunginger JW, Busse WW, Bochner BS, Holgate ST, Simons FER. Philadelphia: Mosby; 2003:644–655.
118.
Gosepath J, Amedee RG, Mann WJ: Nasal provocation testing as an international standard for evaluation of allergic and nonallergic rhinitis. Laryngoscope 2005, 115:512–6.PubMedCrossRef
119.
Melillo G, Bonini S, Cocco G, Davies RJ, de Monchy JG, Frolund L, et al.: EAACI provocation tests with allergens. Report prepared by the European Academy of Allergology and Clinical Immunology Subcommittee on provocation tests with allergens. Allergy 1997, 52:1–35.PubMedCrossRef
120.
Bachert C: Nasal provocation test: critical evaluation. In New trends in allergy IV. Edited by: Ring J, Behrendt HD. Berlin: Springer-Verlag; 1997:277.CrossRef
121.
122.
Lebel B, Bousquet J, Morel A, Chanal I, Godard P, Michel FB: Correlation between symptoms and the threshold for release of mediators in nasal secretions during nasal challenge with grass-pollen grains. J Allergy Clin Immunol 1988, 82:869–77.PubMedCrossRef
123.
Gorski P, Krakowiak A, Pazdrak K, Palczynski C, Ruta U, Walusiak J: Nasal challenge test in the diagnosis of allergic respiratory diseases in subjects occupationally exposed to a high molecular allergen (flour). Occup Med (Lond) 1998, 48:91–7.CrossRef
124.
Guidelines for the diagnosis of occupational asthma. Subcommittee on 'Occupational Allergy' of the European Academy of Allergology and Clinical Immunology Clin Exp Allergy 1992,22(1):103–108.
125.
Moscato G, Dellabianca A, Perfetti L, Brame B, Galdi E, Niniano R, et al.: Occupational asthma: a longitudinal study on the clinical and socioeconomic outcome after diagnosis. Chest 1999, 115:249–56.PubMedCrossRef
126.
Vandenplas O, Toren K, Blanc PD: Health and socioeconomic impact of work-related asthma. Eur Respir J 2003, 22:689–97.PubMedCrossRef
127.
Slovak AJ, Orr RG, Teasdale EL: Efficacy of the helmet respirator in occupational asthma due to laboratory animal allergy (LAA). Am Ind Hyg Assoc J 1985, 46:411–5.PubMedCrossRef
128.
Laoprasert N, Swanson MC, Jones RT, Schroeder DR, Yunginger JW: Inhalation challenge testing of latex-sensitive health care workers and the effectiveness of laminar flow HEPA-filtered helmets in reducing rhinoconjunctival and asthmatic reactions. J Allergy Clin Immunol 1998, 102:998–1004.PubMedCrossRef
129.
Braman SS, Barrows AA, DeCotiis BA, Settipane GA, Corrao WM: Airway hyperresponsiveness in allergic rhinitis. A risk factor for asthma. Chest 1987, 91:671–4.PubMedCrossRef
130.
Laprise C, Boulet LP: Asymptomatic airway hyperresponsiveness: a three-year follow-up. Am J Respir Crit Care Med 1997, 156:403–9.PubMedCrossRef
131.
Boutet K, Malo JL, Ghezzo H, Gautrin D: Airway hyperresponsiveness and risk of chest symptoms in an occupational model. Thorax 2007, 62:260–4.PubMedCrossRef
132.
Porsbjerg C, von Linstow ML, Ulrik CS, Nepper-Christensen SC, Backer V: Outcome in adulthood of asymptomatic airway hyperresponsiveness to histamine and exercise-induced bronchospasm in childhood. Ann Allergy Asthma Immunol 2005, 95:137–42.PubMedCrossRef
133.
Guerra S, Sherrill DL, Martinez FD, Barbee RA: Rhinitis as an independent risk factor for adult-onset asthma. J Allergy Clin Immunol 2002, 109:419–25.PubMedCrossRef
134.
Piirila PL, Keskinen HM, Luukkonen R, Salo SP, Tuppurainen M, Nordman H: Work, unemployment and life satisfaction among patients with diisocyanate induced asthma – a prospective study. J Occup Health 2005, 47:112–8.PubMedCrossRef
135.
Vandenplas O, Jamart J, Delwiche JP, Evrard G, Larbanois A: Occupational asthma caused by natural rubber latex: outcome according to cessation or reduction of exposure. J Allergy Clin Immunol 2002, 109:125–30.PubMedCrossRef
136.
Merget R, Schulte A, Gebler A, Breitstadt R, Kulzer R, Berndt ED, et al.: Outcome of occupational asthma due to platinum salts after transferral to low-exposure areas. Int Arch Occup Environ Health 1999, 72:33–9.PubMedCrossRef
137.
Bernstein DI, Karnani R, Biagini RE, Bernstein CK, Murphy K, Berendts B, et al.: Clinical and occupational outcomes in health care workers with natural rubber latex allergy. Ann Allergy Asthma Immunol 2003, 90:209–13.PubMedCrossRef
138.
Salib RJ, Howarth PH: Remodelling of the upper airways in allergic rhinitis: is it a feature of the disease? Clin Exp Allergy 2003, 33:1629–33.PubMedCrossRef
139.
Bousquet J, Jacot W, Vignola AM, Bachert C, Van Cauwenberge P: Allergic rhinitis: a disease remodeling the upper airways? J Allergy Clin Immunol 2004, 113:43–9.PubMedCrossRef
140.
Sastre J, Quirce S: Immunotherapy: an option in the management of occupational asthma? Curr Opin Allergy Clin Immunol 2006, 6:96–100.PubMedCrossRef
141.
Malone DC, Lawson KA, Smith DH, Arrighi HM, Battista C: A cost of illness study of allergic rhinitis in the United States. J Allergy Clin Immunol 1997, 99:22–7.PubMed
142.
Law AW, Reed SD, Sundy JS, Schulman KA: Direct costs of allergic rhinitis in the United States: estimates from the 1996 Medical Expenditure Panel Survey. J Allergy Clin Immunol 2003, 111:296–300.PubMedCrossRef
143.
Schramm B, Ehlken B, Smala A, Quednau K, Berger K, Nowak D: Cost of illness of atopic asthma and seasonal allergic rhinitis in Germany: 1-yr retrospective study. Eur Respir J 2003, 21:116–22.PubMedCrossRef
144.
Gupta R, Sheikh A, Strachan DP, Anderson HR: Burden of allergic disease in the UK: secondary analyses of national databases. Clin Exp Allergy 2004, 34:520–6.PubMedCrossRef
145.
Yawn BP, Yunginger JW, Wollan PC, Reed CE, Silverstein MD, Harris AG: Allergic rhinitis in Rochester, Minnesota residents with asthma: frequency and impact on health care charges. J Allergy Clin Immunol 1999, 103:54–9.PubMedCrossRef
146.
Ray NF, Baraniuk JN, Thamer M, Rinehart CS, Gergen PJ, Kaliner M, et al.: Direct expenditures for the treatment of allergic rhinoconjunctivitis in including the contributions of related airway illnesses. J Allergy Clin Immunol 1996, 103:401–7.CrossRef
147.
Price D, Zhang Q, Kocevar VS, Yin DD, Thomas M: Effect of a concomitant diagnosis of allergic rhinitis on asthma-related health care use by adults. Clin Exp Allergy 2005, 35:282–7.PubMedCrossRef
148.
Cockburn IM, Bailit HL, Berndt ER, Finkelstein SN: Loss of work productivity due to illness and medical treatment. J Occup Environ Med 1999, 41:948–53.PubMedCrossRef
149.
Gilmore TM, Alexander BH, Mueller BA, Rivara FP: Occupational injuries and medication use. Am J Ind Med 1996, 30:234–9.PubMedCrossRef
150.
Fireman P: Treatment of allergic rhinitis: effect on occupation productivity and work force costs. Allergy Asthma Proc 1997, 18:63–7.PubMedCrossRef
151.
Crystal-Peters J, Crown WH, Goetzel RZ, Schutt DC: The cost of productivity losses associated with allergic rhinitis. Am J Manag Care 2000, 6:373–8.PubMed
152.
Hanrahan LP, Paramore LC: Aeroallergens, allergic rhinitis, and sedating antihistamines: risk factors for traumatic occupational injury and economic impact. Am J Ind Med 2003, 44:438–46.PubMedCrossRef
153.
Blanc PD, Trupin L, Eisner M, Earnest G, Katz PP, Israel L, et al.: The work impact of asthma and rhinitis: findings from a population- based survey. J Clin Epidemiol 2001, 54:610–8.PubMedCrossRef
154.
Demoly P, Allaert FA, Lecasble M: ERASM, a pharmacoepidemiologic survey on management of intermittent allergic rhinitis in every day general medical practice in France. Allergy 2002, 57:546–54.PubMedCrossRef
155.
Brisman J, Jarvholm B: Bakery work, atopy and the incidence of self-reported hay fever and rhinitis. Eur Respir J 1999, 13:502–7.PubMedCrossRef
156.
Bousquet J, Bullinger M, Fayol C, Marquis P, Valentin B, Burtin B: Assessment of quality of life in patients with perennial allergic rhinitis with the French version of the SF-36 Health Status Questionnaire. J Allergy Clin Immunol 1994, 94:182–8.PubMedCrossRef
157.
Meltzer EO, Nathan RA, Selner JC, Storms W: Quality of life and rhinitic symptoms: results of a nationwide survey with the SF-36 and RQLQ questionnaires. J Allergy Clin Immunol 1997, 99:S815–9.CrossRef
158.
159.
Groenewoud GC, de Groot H, van Wijk RG: Impact of occupational and inhalant allergy on rhinitis-specific quality of life in employees of bell pepper greenhouses in the Netherlands. Ann Allergy Asthma Immunol 2006, 96:92–7.PubMedCrossRef
160.
Juniper CP, How MJ, Goodwin BF, Kinshott AK: Bacillus subtilis enzymes: a 7-year clinical, epidemiological and immunological study of an industrial allergen. J Soc Occup Med 1977, 27:3–12.PubMedCrossRef
161.
Schweigert MK, Mackenzie DP, Sarlo K: Occupational asthma and allergy associated with the use of enzymes in the detergent industry – a review of the epidemiology, toxicology and methods of prevention. Clin Exp Allergy 2000, 30:1511–8.PubMedCrossRef
162.
Sarlo K: Control of occupational asthma and allergy in the detergent industry. Ann Allergy Asthma Immunol 2003, 90:32–4.PubMedCrossRef
163.
Hugues EG: Medical surveillance of platinum refinery workers. J Soc Occup Med 1980, 30:27–30.CrossRef
164.
Botham PA, Davies GE, Teasdale EL: Allergy to laboratory animals: a prospective study of its incidence and of the influence of atopy on its development. Br J Ind Med 1987, 44:627–32.PubMedPubMedCentral
165.
Fisher R, Saunders WB, Murray SJ, Stave GM: Prevention of laboratory animal allergy. J Occup Environ Med 1998, 40:609–13.PubMedCrossRef
166.
Gordon S, Preece R: Prevention of laboratory animal allergy. Occup Med (Lond) 2003, 53:371–7.CrossRef
167.
Levy D, Allouache S, Chabane MH, Leynadier F, Burney P: Powder-free protein-poor natural rubber latex gloves and latex sensitization. Jama 1999, 281:988.PubMedCrossRef
168.
Tarlo SM, Easty A, Eubanks K, Parsons CR, Min F, Juvet S, et al.: Outcomes of a natural rubber latex control program in an Ontario teaching hospital. J Allergy Clin Immunol 2001, 108:628–33.PubMedCrossRef
169.
Saary MJ, Kanani A, Alghadeer H, Holness DL, Tarlo SM: Changes in rates of natural rubber latex sensitivity among dental school students and staff members after changes in latex gloves. J Allergy Clin Immunol 2002, 109:131–5.PubMedCrossRef
170.
Allmers H, Schmengler J, Skudlik C: Primary prevention of natural rubber latex allergy in the German health care system through education and intervention. J Allergy Clin Immunol 2002, 110:318–23.PubMedCrossRef
171.
Latza U, Haamann F, Baur X: Effectiveness of a nationwide interdisciplinary preventive programme for latex allergy. Int Arch Occup Environ Health 2005, 78:394–402.PubMedCrossRef
172.
Eggleston PA, Ansari AA, Ziemann B, Adkinson NF Jr, Corn M: Occupational challenge studies with laboratory workers allergic to rats. J Allergy Clin Immunol 1990, 86:63–72.PubMedCrossRef
173.
Quirce S, Swanson MC, Fernandez-Nieto M, de las Heras M, Cuesta J, Sastre J: Quantified environmental challenge with absorbable dusting powder aerosol from natural rubber latex gloves. J Allergy Clin Immunol 2003, 111:788–94.PubMedCrossRef
174.
Heederik D, Houba R: An exploratory quantitative risk assessment for high molecular weight sensitizers: wheat flour. Ann Occup Hyg 2001, 45:175–85.PubMedCrossRef
175.
Cullinan P, Lowson D, Nieuwenhuijsen MJ, Gordon S, Tee RD, Venables KM, et al.: Work related symptoms, sensitisation, and estimated exposure in workers not previously exposed to laboratory rats. Occup Environ Med 1994, 51:589–92.PubMedPubMedCentralCrossRef
176.
Baur X, Chen Z, Allmers H: Can a threshold limit value for natural rubber latex airborne allergens be defined? J Allergy Clin Immunol 1998, 101:24–7.PubMedCrossRef
177.
Chan-Yeung M, Malo JL, Tarlo SM, Bernstein L, Gautrin D, Mapp C, et al.: Proceedings of the first Jack Pepys Occupational Asthma Symposium. Am J Respir Crit Care Med 2003, 167:450–71.PubMedCrossRef
178.
Cullinan P, Tarlo S, Nemery B: The prevention of occupational asthma. Eur Respir J 2003, 22:853–60.PubMedCrossRef
179.
Nicholson PJ, Cullinan P, Taylor AJ, Burge PS, Boyle C: Evidence based guidelines for the prevention, identification, and management of occupational asthma. Occup Environ Med 2005, 62:290–9.PubMedPubMedCentralCrossRef
180.
Tarlo SM, Liss GM: Practical implications of studies in occupational rhinoconjunctivitis. J Allergy Clin Immunol 2003, 112:1047–9.PubMedCrossRef
181.
Walusiak J, Palczynski C, Hanke W, Wittczak T, Krakowiak A, Gorski P: The risk factors of occupational hypersensitivity in apprentice bakers – the predictive value of atopy markers. Int Arch Occup Environ Health 2002,75(Suppl):S117–21.PubMedCrossRef
182.
Nguyen B, Ghezzo H, Malo JL, Gautrin D: Time course of onset of sensitization to common and occupational inhalants in apprentices. J Allergy Clin Immunol 2003, 111:807–12.PubMedCrossRef
183.
Gautrin D, Infante-Rivard C, Ghezzo H, Malo JL: Incidence and host determinants of probable occupational asthma in apprentices exposed to laboratory animals. Am J Respir Crit Care Med 2001, 163:899–904.PubMedCrossRef
184.
Gautrin D, Ghezzo H, Infante-Rivard C, Malo JL: Incidence and determinants of IgE-mediated sensitization in apprentices. A prospective study. Am J Respir Crit Care Med 2000, 162:1222–8.PubMedCrossRef
185.
Nicholson PJ, Newman Taylor AJ, Oliver P, Cathcart M: Current best practice for the health surveillance of enzyme workers in the soap and detergent industry. Occup Med (Lond) 2001, 51:81–92.CrossRef
186.
Gannon PF, Berg AS, Gayosso R, Henderson B, Sax SE, Willems HM: Occupational asthma prevention and management in industry – an example of a global programme. Occup Med (Lond) 2005, 55:600–5.CrossRef
187.
Merget R, Caspari C, Dierkes-Globisch A, Kulzer R, Breitstadt R, Kniffka A, et al.: Effectiveness of a medical surveillance program for the prevention of occupational asthma caused by platinum salts: a nested case-control study. J Allergy Clin Immunol 2001, 107:707–12.PubMedCrossRef
188.
Grammer L, Shaughnessy M, Kenamore B: Utility of antibody in identifying individuals who have or will develop anhydride-induced respiratory disease. Chest 1998, 114:1199–202.PubMedCrossRef
189.
de Graaf-in 't Veld T, Koenders S, Garrelds IM, Gerth van Wijk R: The relationships between nasal hyperreactivity, quality of life, and nasal symptoms in patients with perennial allergic rhinitis. J Allergy Clin Immunol 1996, 98:508–13.PubMedCrossRef
190.
Young T, Finn L, Kim H: Nasal obstruction as a risk factor for sleep-disordered breathing. The University of Wisconsin Sleep and Respiratory Research Group. J Allergy Clin Immunol 1997, 99:S757–62.PubMedCrossRef
191.
Stuck BA, Czajkowski J, Hagner AE, Klimek L, Verse T, Hormann K, et al.: Changes in daytime sleepiness, quality of life, and objective sleep patterns in seasonal allergic rhinitis: a controlled clinical trial. J Allergy Clin Immunol 2004, 113:663–8.PubMedCrossRef
192.
Leger D, Annesi-Maesano I, Carat F, Rugina M, Chanal I, Pribil C, et al.: Allergic rhinitis and its consequences on quality of sleep: An unexplored area. Arch Intern Med 2006, 166:1744–8.PubMedCrossRef
193.
Juniper EF: Quality of life in adults and children with asthma and rhinitis. Allergy 1997, 52:971–7.PubMedCrossRef
194.
Juniper EF, Thompson AK, Ferrie PJ, Roberts JN: Development and validation of the mini Rhinoconjunctivitis Quality of Life Questionnaire. Clin Exp Allergy 2000, 30:132–40.PubMedCrossRef
195.
Benninger MS, Senior BA: The development of the Rhinosinusitis Disability Index. Arch Otolaryngol Head Neck Surg 1997, 123:1175–9.PubMedCrossRef
196.
Senior BA, Glaze C, Benninger MS: Use of the Rhinosinusitis Disability Index (RSDI) in rhinologic disease. Am J Rhinol 2001, 15:15–20.PubMedCrossRef
197.
Fokkens W, Lund V, Bachert C, Clement P, Helllings P, Holmstrom M, et al.: EAACI position paper on rhinosinusitis and nasal polyps executive summary. Allergy 2005, 60:583–601.PubMedCrossRef
198.
Spector SL, Nicklas RA, Chapman JA, Bernstein IL, Berger WE, Blessing-Moore J, et al.: Symptom severity assessment of allergic rhinitis: part 1. Ann Allergy Asthma Immunol 2003, 91:105–14.PubMedCrossRef
199.
Fokkens W, Lund V, Mullol J, et al.: European Position Paper on Rhinosinusitis and Nasal Polyps 2007. Rhinology 2007, 45:1–36.
200.
Bousquet J, Neukirch F, Bousquet PJ, Gehano P, Klossek JM, Le Gal M, et al.: Severity and impairment of allergic rhinitis in patients consulting in primary care. J Allergy Clin Immunol 2006, 117:158–62.PubMedCrossRef
201.
Bousquet PJ, Combescure C, Neukirch F, Klossek JM, Mechin H, Daures JP, et al.: Visual analog scales can assess the severity of rhinitis graded according to ARIA guidelines. Allergy 2007, 62:367–72.PubMedCrossRef
202.
Bachert C, van Cauwenberge P, Olbrecht J, van Schoor J: Prevalence, classification and perception of allergic and nonallergic rhinitis in Belgium. Allergy 2006, 61:693–8.PubMedCrossRef
203.
Block G, Tse KS, Kijek K, Chan H, Chan-Yeung M: Baker's asthma. Clinical and immunological studies. Clin Allergy 1983, 13:359–70.PubMed
204.
Vandenplas O, Cartier A, Malo JL: Occupational challenge tests. In Asthma in the workplace. Edited by: Bernstein IL, Chan-Yeung M, Malo JL, Bernstein D. New York: Taylor & Francis; 2006:227–252.CrossRef
205.
Vandenplas O, Malo JL: Inhalation challenges with agents causing occupational asthma. Eur Respir J 1997, 10:2612–29.PubMedCrossRef
206.
Heldal KK, Halstensen AS, Thorn J, Djupesland P, Wouters I, Eduard W, et al.: Upper airway inflammation in waste handlers exposed to bioaerosols. Occup Environ Med 2003, 60:444–50.PubMedPubMedCentralCrossRef
207.
Ahman M: Nasal peak flow rate records in work related nasal blockage. Acta Otolaryngol 1992, 112:839–44.PubMedCrossRef
208.
Ahman M, Soderman E: Serial nasal peak expiratory flow measurements in woodwork teachers. Int Arch Occup Environ Health 1996, 68:177–82.PubMedCrossRef
209.
Naclerio RM, Meier HL, Kagey-Sobotka A, Adkinson NF Jr, Meyers DA, Norman PS, et al.: Mediator release after nasal airway challenge with allergen. Am Rev Respir Dis 1983, 128:597–602.PubMed
210.
Palczynski C, Walusiak J, Ruta U, Gorski P: Nasal provocation test in the diagnosis of natural rubber latex allergy. Allergy 2000, 55:34–41.PubMedCrossRef
211.
Raulf-Heimsoth M, Wirtz C, Papenfuss F, Baur X: Nasal lavage mediator profile and cellular composition of nasal brushing material during latex challenge tests. Clin Exp Allergy 2000, 30:110–21.PubMedCrossRef
212.
Walusiak J, Wiszniewska M, Krawczyk-Adamus P, Palczynski C: Occupational allergy to wheat flour. Nasal response to specific inhalative challenge in asthma and rhinitis vs. isolated rhinitis: a comparative study. Int J Occup Med Environ Health 2004, 17:433–40.PubMed
213.
Palczynski C, Walusiak J, Ruta U, Gorski P: Occupational asthma and rhinitis due to glutaraldehyde: changes in nasal lavage fluid after specific inhalatory challenge test. Allergy 2001, 56:1186–91.PubMedCrossRef
214.
Wittczak T, Walusiak J, Ruta U, Palczynski C: Occupational asthma and allergic rhinitis due to xerographic toner. Allergy 2003, 58:957.PubMedCrossRef
215.
Boot JD, de Kam ML, Mascelli MA, Miller B, van Wijk RG, de Groot H, et al.: Nasal nitric oxide: longitudinal reproducibility and the effects of a nasal allergen challenge in patients with allergic rhinitis. Allergy 2007, 62:378–84.PubMedCrossRef
216.
217.
Juliusson S, Bende M: Priming effect of a birch pollen season studied with laser Doppler flowmetry in patients with allergic rhinitis. Clin Allergy 1988, 18:615–8.PubMedCrossRef
218.
Crimi E, Voltolini S, Gianiorio P, Orengo G, Troise C, Brusasco V, et al.: Effect of seasonal exposure to pollen on specific bronchial sensitivity in allergic patients. J Allergy Clin Immunol 1990, 85:1014–9.PubMedCrossRef
219.
Ciprandi G, Ricca V, Landi M, Passalacqua G, Bagnasco M, Canonica GW: Allergen-specific nasal challenge: response kinetics of clinical and inflammatory events to rechallenge. Int Arch Allergy Immunol 1998, 115:157–61.PubMedCrossRef
Metadata
Title
EAACI position paper on occupational rhinitis
Authors
Gianna Moscato
Olivier Vandenplas
Roy Gerth Van Wijk
Jean-Luc Malo
Luca Perfetti
Santiago Quirce
Jolanta Walusiak
Roberto Castano
Gianni Pala
Denyse Gautrin
Hans De Groot
Ilenia Folletti
Mona Rita Yacoub
Andrea Siracusa
Publication date
01-12-2009
Publisher
BioMed Central
Published in
Respiratory Research / Issue 1/2009
Electronic ISSN: 1465-993X
DOI
https://doi.org/10.1186/1465-9921-10-16

Other articles of this Issue 1/2009

Respiratory Research 1/2009 Go to the issue

Research

Antenatal and postnatal corticosteroid and resuscitation induced lung injury in preterm sheep

Research

Synthetic RGDS peptide attenuates lipopolysaccharide-induced pulmonary inflammation by inhibiting integrin signaled MAP kinase pathways

Research

Asthma and genes encoding components of the vitamin D pathway

Research

Novel autoantigens immunogenic in COPD patients

Research

Down-regulation of the inhibitor of growth family member 4 (ING4) in different forms of pulmonary fibrosis

Research

Oxidative stress augments toll-like receptor 8 mediated neutrophilic responses in healthy subjects
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits